U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by BlackRock Inc.

BlackRock Inc. increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 166,319.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,554,353 shares of the company’s stock after buying an additional 1,553,419 shares during the period. BlackRock Inc. owned approximately 12.44% of U.S. Physical Therapy worth $101,501,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of USPH. Trexquant Investment LP purchased a new stake in shares of U.S. Physical Therapy during the first quarter valued at $666,000. Kings Point Capital Management boosted its stake in shares of U.S. Physical Therapy by 2.4% in the first quarter. Kings Point Capital Management now owns 26,471 shares of the company’s stock valued at $1,729,000 after buying an additional 625 shares during the last quarter. Advisors Preferred LLC boosted its stake in shares of U.S. Physical Therapy by 17.1% in the first quarter. Advisors Preferred LLC now owns 4,046 shares of the company’s stock valued at $264,000 after buying an additional 591 shares during the last quarter. US Bancorp DE boosted its stake in shares of U.S. Physical Therapy by 6.9% in the first quarter. US Bancorp DE now owns 5,173 shares of the company’s stock valued at $338,000 after buying an additional 333 shares during the last quarter. Finally, Capital Fund Management S.A. purchased a new stake in shares of U.S. Physical Therapy during the first quarter valued at $444,000. 95.73% of the stock is currently owned by hedge funds and other institutional investors.

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) opened at 59.25 on Friday. The company has a market capitalization of $745.42 million, a price-to-earnings ratio of 37.50 and a beta of 1.06. The stock has a 50 day moving average of $62.30 and a 200-day moving average of $65.75. U.S. Physical Therapy, Inc. has a 52 week low of $51.96 and a 52 week high of $78.00.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.60 by $0.01. The company had revenue of $104.25 million during the quarter, compared to analyst estimates of $102.93 million. U.S. Physical Therapy had a net margin of 5.65% and a return on equity of 12.91%. On average, analysts anticipate that U.S. Physical Therapy, Inc. will post $2.13 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 8th. Stockholders of record on Monday, August 21st will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, August 17th. U.S. Physical Therapy’s payout ratio is currently 46.78%.

WARNING: “U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by BlackRock Inc.” was first reported by BNB Daily and is the property of of BNB Daily. If you are accessing this piece on another site, it was stolen and reposted in violation of U.S. and international copyright and trademark law. The original version of this piece can be read at https://www.baseball-news-blog.com/2017/08/19/blackrock-inc-has-101-50-million-position-in-u-s-physical-therapy-inc-nyseusph-updated-updated.html.

Several equities research analysts have recently commented on the stock. Jefferies Group LLC set a $65.00 target price on shares of U.S. Physical Therapy and gave the stock a “hold” rating in a research report on Friday, August 4th. Cantor Fitzgerald started coverage on shares of U.S. Physical Therapy in a research report on Monday, July 24th. They issued an “overweight” rating and a $72.00 target price for the company. BidaskClub lowered shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a research note on Sunday, July 16th. Barrington Research upgraded shares of U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $68.00 price target for the company in a research note on Monday, July 3rd. Finally, Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $69.00 price target for the company in a research note on Friday, June 23rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $68.50.

In related news, Director Bernard A. Harris, Jr. sold 5,000 shares of the company’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $62.00, for a total transaction of $310,000.00. Following the transaction, the director now owns 26,422 shares of the company’s stock, valued at $1,638,164. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Lawrance W. Mcafee sold 3,000 shares of the company’s stock in a transaction on Friday, August 11th. The stock was sold at an average price of $62.04, for a total value of $186,120.00. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply